Genocea Biosciences, Inc. ( GNCA) - Stock Earnings

GNCA Quarterly earnings

DateEarningsRevenue
2021Q3 -3.6 million USD 1.6 million USD
2021Q4 -13.3 million USD 0 USD
2022Q1 -16.0 million USD 270000 USD

GNCA Yearly earnings

DateEarningsRevenue
2019 -39.0 million USD 0 USD
2020 -43.7 million USD 1.4 million USD
2021 -33.2 million USD 1.6 million USD

GNCA

Price: $0

52 week price:
0.00
1.48

Earnings Per Share: -0.78 USD

P/E Ratio: -1.64

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 13853

Ebitda: -10.1 million

Market Capitalization: 396373

Links: